Get startedLog in
    Picture of Immix Biopharma logo

    IMMX — Immix Biopharma News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid CapNeutral
    All News

    Brief: Immix Biopharma Announces Positive U.S. Clinical Data From First Four Patients In Nexicart-2 U.S. Trial

    Picture of Immix Biopharma logoImmix Biopharma
    19/12/2024 18:04
    Dec 19 (Reuters) - Immix Biopharma Inc  IMMX.O :
    * IMMIX BIOPHARMA ANNOUNCES POSITIVE U.S. CLINICAL DATA FROM
FIRST
FOUR PATIENTS IN NEXICART-2 U.S. TRIAL OF STERICALLY-OPTIMIZED
CAR-T NXC-201 IN RELAPSED/REFRACTORY LIGHT CHAIN (AL)
AMYLOIDOSIS

Source text:  ID:nGNX8FVKlw 
Further company coverage:  IMMX.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Immix Biopharma

    See all news